In Silico Functional Meta-Analysis of 5,962 ABCA4 Variants in 3,928 Retinal Dystrophy Cases

被引:101
作者
Cornelis, Stephanie S. [1 ,2 ]
Bax, Nathalie M. [2 ,3 ]
Zernant, Jana [4 ]
Allikmets, Rando [4 ,5 ]
Fritsche, Lars G. [6 ]
den Dunnen, Johan T. [7 ]
Ajmal, Muhammad [8 ]
Hoyng, Carel B. [2 ,3 ]
Cremers, Frans P. M. [1 ,3 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[4] Columbia Univ, Dept Ophthalmol, New York, NY 10027 USA
[5] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA
[6] Norwegian Univ Sci & Technol, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol, NTNU, Trondheim, Norway
[7] Leiden Univ, Dept Clin Genet & Human Genet, Med Ctr, Leiden, Netherlands
[8] COMSATS Inst Informat Technol, Dept Biosci, Fac Sci, Islamabad, Pakistan
关键词
ABCA4; retinal dystrophy; meta-analysis; genotype-phenotype correlation; in silico prediction; mild variants; STARGARDT-DISEASE GENE; RECESSIVE RETINITIS-PIGMENTOSA; CONE-ROD DYSTROPHY; TRANSPORTER GENE; MUTATIONS; GENOTYPE; BINDING; PHENOTYPE; REVEALS; ASSOCIATION;
D O I
10.1002/humu.23165
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Variants in the ABCA4 gene are associated with a spectrum of inherited retinal diseases (IRDs), most prominently with autosomal recessive (ar) Stargardt disease (STGD1) and ar cone-rod dystrophy. The clinical outcome to a large degree depends on the severity of the variants. To provide an accurate prognosis and to select patients for novel treatments, functional significance assessment of nontruncating ABCA4 variants is important. We collected all published ABCA4 variants from 3,928 retinal dystrophy cases in a Leiden Open Variation Database, and compared their frequency in 3,270 Caucasian IRD cases with 33,370 non-Finnish European control individuals. Next to the presence of 270 protein-truncating variants, 191 nontruncating variants were significantly enriched in the patient cohort. Furthermore, 30 variants were deemed benign. Assessing the homozygous occurrence of frequent variants in IRD cases based on the allele frequencies in control individuals confirmed the mild nature of the p.[Gly863Ala, Gly863del] variant and identified three additional mild variants (p.(Ala1038Val), c.5714+5G>A, and p.(Arg2030Gln)). The p.(Gly1961Glu) variant was predicted to act as a mild variant in most cases. Based on these data, in silico analyses, and American College of Medical Genetics and Genomics guidelines, we provide pathogenicity classifications on a five-tier scale from benign to pathogenic for all variants in the ABCA4-LOVD database. (C) 2017 Wiley Periodicals, Inc.
引用
收藏
页码:400 / 408
页数:9
相关论文
共 57 条
[1]   Functional interaction between the two halves of the photoreceptor-specific ATP binding cassette protein ABCR (ABCA4) - Evidence for a non-exchangeable ADP in the first nucleotide binding domain [J].
Ahn, JH ;
Beharry, S ;
Molday, LL ;
Molday, RS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) :39600-39608
[2]   A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy [J].
Allikmets, R ;
Singh, N ;
Sun, H ;
Shroyer, NE ;
Hutchinson, A ;
Chidambaram, A ;
Gerrard, B ;
Baird, L ;
Stauffer, D ;
Peiffer, A ;
Rattner, A ;
Smallwood, P ;
Li, YX ;
Anderson, KL ;
Lewis, RA ;
Nathans, J ;
Leppert, M ;
Dean, M ;
Lupski, JR .
NATURE GENETICS, 1997, 15 (03) :236-246
[3]   Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration [J].
Allikmets, R ;
Shroyer, NF ;
Singh, N ;
Seddon, JM ;
Lewis, RA ;
Bernstein, PS ;
Peiffer, A ;
Zabriskie, NA ;
Li, YX ;
Hutchinson, A ;
Dean, M ;
Lupski, JR ;
Leppert, M .
SCIENCE, 1997, 277 (5333) :1805-1807
[4]   An Augmented ABCA4 Screen Targeting Noncoding Regions Reveals a Deep Intronic Founder Variant in Belgian Stargardt Patients [J].
Bauwens, Miriam ;
De Zaeytijd, Julie ;
Weisschuh, Nicole ;
Kohl, Susanne ;
Meire, Francoise ;
Dahan, Karin ;
Depasse, Fanny ;
De Jaegere, Sarah ;
De Ravel, Thomy ;
De Rademaeker, Marjan ;
Loeys, Bart ;
Coppieters, Frauke ;
Leroy, Bart P. ;
De Baere, Elfride .
HUMAN MUTATION, 2015, 36 (01) :39-42
[5]   Heterozygous Deep-Intronic Variants and Deletions in ABCA4 in Persons with Retinal Dystrophies and One Exonic ABCA4 Variant [J].
Bax, Nathalie M. ;
Sangermano, Riccardo ;
Roosing, Susanne ;
Thiadens, Alberta A. H. J. ;
Hoefsloot, Lies H. ;
van den Born, L. Ingeborgh ;
Phan, Milan ;
Klevering, B. Jeroen ;
Westeneng-van Haaften, Carla ;
Braun, Terry A. ;
Zonneveld-Vrieling, Marijke N. ;
de Wijs, Ilse ;
Mutlu, Merve ;
Stone, Edwin M. ;
den Hollander, Anneke I. ;
Klaver, Caroline C. W. ;
Hoyng, Carel B. ;
Cremers, Frans P. M. .
HUMAN MUTATION, 2015, 36 (01) :43-47
[6]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[7]   Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease [J].
Braun, Terry A. ;
Mullins, Robert F. ;
Wagner, Alex H. ;
Andorf, Jeaneen L. ;
Johnston, Rebecca M. ;
Bakall, Benjamin B. ;
Deluca, Adam P. ;
Fishman, Gerald A. ;
Lam, Byron L. ;
Weleber, Richard G. ;
Cideciyan, Artur V. ;
Jacobson, Samuel G. ;
Sheffield, Val C. ;
Tucker, Budd A. ;
Stone, Edwin M. .
HUMAN MOLECULAR GENETICS, 2013, 22 (25) :5136-5145
[8]   ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571
[9]   Regulation of DNA binding by Rel/NF-κB transcription factors:: structural views [J].
Chen, FE ;
Ghosh, G .
ONCOGENE, 1999, 18 (49) :6845-6852
[10]   Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290 [J].
Collin, Rob W. J. ;
den Hollander, Anneke I. ;
van der Velde-Visser, Saskia D. ;
Bennicelli, Jeannette ;
Bennett, Jean ;
Cremers, Frans P. M. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1 :e14